Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1105 | 1016 | 1167 | 1300 | 1376 | 2021 |
Fund Return | 10.47% | 1.58% | 16.71% | 9.14% | 6.59% | 7.29% |
Place in category | 162 | 365 | 119 | 52 | 89 | 16 |
% in Category | 39 | 76 | 33 | 11 | 23 | 5 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Fund | 5.06B | 10.08 | 8.25 | 6.32 | ||
Royal London FTSE 350 Tracker Z Fun | 5.06B | 10.06 | 8.07 | 6.28 | ||
Royal London European Growth Fund C | 2.33B | 5.25 | 5.75 | 8.44 | ||
Royal London US Tracker Z Fund Accu | 1.35B | 14.14 | 10.09 | 14.76 | ||
Royal London UK Equity Income A | 1.13B | 10.12 | 8.72 | 6.67 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.05B | 12.38 | 8.81 | 7.01 | ||
TB Evenlode Income B Income | 3.27B | 5.22 | 5.85 | 8.72 | ||
UK Equity Income Fund Institutional | 90.61M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Retail Income | 137.7M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Retail Accumu | 115.21M | 9.74 | 6.41 | 6.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.80 | 31.40 | +0.62% | |
AstraZeneca | GB0009895292 | 4.66 | 10,070.0 | -8.80% | |
Unilever | GB00B10RZP78 | 4.12 | 56.22 | -0.21% | |
Relx | GB00B2B0DG97 | 4.02 | 3,656.00 | +1.08% | |
Imperial Brands | GB0004544929 | 3.47 | 2,382.00 | +0.97% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review